Filter
416
Text search:
mutation
Featured
Recommendations
57
New Publications
95
Language
Document type
No document type
184
Guidelines
84
Studies & Reports
71
Manuals
24
Strategic & Response Plan
18
Training Material
13
Fact sheets
12
Videos
4
Situation Updates
3
Resource Platforms
2
Brochures
1
Countries / Regions
India
23
Global
12
Western and Central Europe
10
Africa
10
Ethiopia
9
South Africa
9
Cameroon
8
Latin America and the Carribbean
8
Burkina Faso
6
Haiti
6
Germany
6
Nigeria
5
Congo, Democratic Republic of
5
Nepal
5
Senegal
4
Tanzania
4
Benin
4
Namibia
4
Liberia
3
Uganda
3
Zambia
3
Middle East and North Africa
3
Eastern Europe
3
Sierra Leone
2
Mali
2
Morocco
2
Niger
2
Togo
2
Kenya
2
Cambodia
2
Thailand
2
China
2
Rwanda
2
Bangladesh
2
Mozambique
2
Brazil
2
Bolivia
2
Madagascar
2
Myanmar / Burma
2
Asia
2
Russia
2
Vietnam
2
France
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Zimbabwe
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Syria
1
Chad
1
Indonesia
1
Mauritania
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
Cuba
1
Ukraine
1
Colombia
1
Honduras
1
Ecuador
1
Botswana
1
El Salvador
1
Libya
1
Guatemala
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Venezuela
1
Laos
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
128
Clinical Guidelines
49
Public Health
26
Pharmacy & Technologies
12
Key Resources
8
Women & Child Health
6
Capacity Building
3
Annual Report MEDBOX
1
Toolboxes
COVID-19
69
TB
51
HIV
33
Malaria
23
AMR
22
Mental Health
15
Pharmacy
15
NTDs
14
Ebola & Marburg
10
Planetary Health
10
Rapid Response
9
NCDs
9
Refugee
7
Caregiver
6
2.0 Rapid Response
6
Disability
4
Polio
2
Zika
2
Natural Hazards
1
Specific Hazards
1
Health Financing Toolbox
1
Asbestos, the most frequent cause of occupational cancer, continues to be consumed ona massive scale, with millions of people exposed on a daily basis. This review explains why we havefailed in curtailing the silent epidemic of asbestos-related disease and why the numbers of asbestosvictims are like
...
This report provides an overview of the main findings of the 2019–2020 harmonised AMR monitoring in the main food-producing animal populations monitored, in carcase/meat samples and in humans. Where available, monitoring data obtained from pigs, calves, broilers, laying hens and turkeys, as well a
...
Bulletin of the World Health Organization 2016. doi: http://dx.doi.org/10.2471/BLT.16.171082
Objective: To describe the temporal and geographical distribution of Zika virus infection, and associated neurological disorders, from 1947 to February 2016.
Working Document, September 2017
Evaluation on the Unicef valuation of the UNICEF PMTCT / paediatric HIV care and Treatment programme
Evaluation Report
Evaluation Office
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for viral-load testing and standard operating procedure
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w
...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List
...
Morbidity and Mortality Weekly Report (MMWR) Early Release Vol. 64 ; 1 May 2015
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.